4,4'- (2,2- bis((4- (aminoiminomethyl)- 2- bromophenoxy)methyl)- 1,3- propanediyl)bis(oxy))bis(3- bromobenzenecarboximidamide
structure given in first source
Networked: 4
relevant articles (0 outcomes,
1 trials/studies)
Bio-Agent Context: Research Results
Related Diseases
1. | Neoplasms (Cancer)
|
2. | Melanoma (Melanoma, Malignant)
|
3. | Carcinoma (Carcinomatosis)
07/01/1992
- " TAPP-Br inhibited the cell growth of all the colon carcinoma cell lines, and this effect was irreversible. " 08/01/1990
- " Apart from its antiproteinase activity, the aromatic polyamidine TAPP-Br [the bromo derivative of 1,3-di-(p-amidinophenoxy)-2,2-bis-(p-amidinophenoxymethyl)propane (TAPP-H)] is able to inhibit the in vitro growth of a variety of tumor cell lines, including human melanoma, and breast and kidney carcinoma. " 07/01/1992
- " These findings overall suggest that the serine protease inhibitor, TAPP-Br, might inhibit the cell growth of colon carcinoma cell lines through suppressing the expression of genes whose promoter contains a 12-O-tetradecanoylphorbol-13-acetate-responsive element or serum-responsive element." 07/01/1992
- " The inhibitory effect of a serine protease-inhibiting tetra-benzamidine derivative, TAPP-Br, on the cell growth of 8 human colon carcinoma cell lines was examined and the mechanism of the inhibition was analyzed. "
|
4. | Leukemia
|
|
Related Drugs and Biologics
Related Therapies and Procedures